SCF Pharma   Report issue

For profit Phase 2 Phase 4
Founded: Quebec City Canada (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2015
NCT02518672
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Samuel Fortin | SCF Pharma